At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data
Mathai, David S., Hull, Thomas D., Vando, Leonardo, Malgaroli, Matteo
Published in Journal of affective disorders (15.09.2024)
Published in Journal of affective disorders (15.09.2024)
Get full text
Journal Article
At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial
Hull, Thomas D., Malgaroli, Matteo, Gazzaley, Adam, Akiki, Teddy J., Madan, Alok, Vando, Leonardo, Arden, Kristin, Swain, Jack, Klotz, Madeline, Paleos, Casey
Published in Journal of affective disorders (01.10.2022)
Published in Journal of affective disorders (01.10.2022)
Get full text
Journal Article